Attorneys and life sciences companies expressed concern that, as a result of the Supreme Court's June 6 ruling that the Bayh-Dole Act does not bar inventors from assigning their individual rights in patents resulting from federally funded research, a research organization's efforts to properly secure rights to that invention will become more complicated and more demands will be placed on life sciences research than on other areas.
Reproduced with permission from Life Sciences Law & Industry Report, 5 LSLR 597 (June 17, 2011). Copyright 2011 by The Bureau of National Affairs, Inc. (800-372-1033) http://www.bna.com.
